Providence Therapeutics Announces Formation of Oncology Clinical Advisory Board
CALGARY, AB, Sept. 29, 2026 /PRNewswire/ -- Providence Therapeutics Holdings, Inc. is pleased to announce formation of its initial Clinical Advisory Board. This advisory group will help steer Providence's therapeutic mRNA cancer vaccine programs, including the Company's personalized vaccine program for pediatric brain cancer patients as well as the Company's off-the-shelf precision therapy vaccines for a range of solid tumor cancers. Providence's Clinical Advisory Board will be chaired by the Co...